Reference : Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d...
Scientific journals : Article
Human health sciences : Gastroenterology & hepatology
http://hdl.handle.net/2268/69674
Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d'Etude des Virus Hépatotropes.
French
[en] Evidence-based medicine: treatment of chronic hepatitis C. Liege Study Group on Viral Hepatitis
Delwaide, Jean mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gastro-Entérologie-Hépatologie >]
Gerard, Christiane mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie biologique et immuno hématologie >]
Belaiche, Jacques mailto [Université de Liège - ULg > > Gastro-Entérologie-Hépatologie >]
Maggipinto, Gianni mailto [Université de Liège - ULg > > Hématologie biologique et immuno hématologie >]
Vaira, Dolorès mailto [Université de Liège - ULg > > Hématologie biologique et immuno hématologie >]
Rentier, Bernard mailto [Université de Liège - ULg > Sciences de la Vie > GIGA-R : Virologie - Immunologie > >]
2000
Revue Médicale de Liège
55
5
337-340
Yes (verified by ORBi)
National
0370-629X
BELGIUM
[en] Carcinoma, Hepatocellular/etiology ; Evidence-Based Medicine ; Hepacivirus/pathogenicity ; Hepatitis C, Chronic/complications/drug therapy ; Humans ; Liver Cirrhosis/etiology ; Liver Neoplasms/etiology
[en] The Hepatitis C virus (HCV) infects nearly 170 million people in the world. The major characteristic of virus C is its tendency to chronicity in more than 85% of cases. Generally asymptomatic, HCV infection may also evolve with time to cirrhosis and hepatocellular carcinoma. During the last few years, HCV-related end-stage cirrhosis has become the first cause of liver transplantation. In 10 years only, very significant progress has been made in the knowledge of the virus, not only in the field of diagnosis but also in therapy. Several consensus conferences taking last discoveries into account have been organized in order to promote recommendations useful for the management of hepatitis C patients. The aim of this short overview is to summarize practical recommendations that emerged recently from consensus meetings.
Researchers ; Professionals
http://hdl.handle.net/2268/69674

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Delwaide_2000_RML_337.pdfPublisher postprint818.64 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.